Literature DB >> 12868491

The formation of phosphatidylcholine oxidation products by stimulated phagocytes.

Andreas Jerlich1, R Jörg Schaur, Andrew R Pitt, Corinne M Spickett.   

Abstract

Phagocytic cells produce a variety of oxidants as part of the immune defence, which react readily both with proteins and lipids, and could contribute to the oxidation of low density lipoprotein in atherosclerosis. We have investigated the oxidation of phospholipid vesicles by neutrophils and mononuclear cells, to provide a model of lipid oxidation in the absence of competing protein. Phorbol 12-myristate 13-acetate-stimulated neutrophils were incubated with phospholipid vesicles containing dipalmitoyl phosphatidylcholine, palmitoyl-arachidonoyl phosphatidylcholine (PAPC) and stearoyl-oleoyl phosphatidylcholine, before extraction of the lipids for analysis by HPLC coupled to electrospray mass spectrometry. The formation of monohydroperoxides (814 m/z) and bishydroperoxides (846 m/z) of PAPC was observed. However, the major oxidized product occurred at 828 m/z,and was identified as 1-palmitoyl-2-(5,6-epoxyisoprostane E2)-sn-glycero-3-phosphocholine. These products were also formed in incubations where the neutrophils were replaced by mononuclear cells, and the amounts produced per million cells were similar. These results show that following oxidative attack by phagocytes stimulated by PMA, intact phospholipid oxidation products can be detected. The identification of an epoxyisoprostane phospholipid as the major product of phagocyte-induced phospholipid oxidation is novel, and in view of its inflammatory properties has implications for phagocyte involvement in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12868491     DOI: 10.1080/1071576031000091720

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  4 in total

Review 1.  Generation and biological activities of oxidized phospholipids.

Authors:  Valery N Bochkov; Olga V Oskolkova; Konstantin G Birukov; Anna-Liisa Levonen; Christoph J Binder; Johannes Stöckl
Journal:  Antioxid Redox Signal       Date:  2010-04-15       Impact factor: 8.401

2.  Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC.

Authors:  Anna A Birukova; Vitaliy Starosta; Xinyong Tian; Katherine Higginbotham; Lukas Koroniak; Judith A Berliner; Konstantin G Birukov
Journal:  Transl Res       Date:  2013-01-08       Impact factor: 7.012

3.  Anti-myeloperoxidase antibodies attenuate the monocyte response to LPS and shape macrophage development.

Authors:  Reena J Popat; Seran Hakki; Alpesh Thakker; Alice M Coughlan; Julie Watson; Mark A Little; Corinne M Spickett; Paul Lavender; Behdad Afzali; Claudia Kemper; Michael G Robson
Journal:  JCI Insight       Date:  2017-01-26

Review 4.  Chlorinated Phospholipids and Fatty Acids: (Patho)physiological Relevance, Potential Toxicity, and Analysis of Lipid Chlorohydrins.

Authors:  Jenny Schröter; Jürgen Schiller
Journal:  Oxid Med Cell Longev       Date:  2016-12-20       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.